In rat GH secreting tumour cell lines, in studies using octreotide and pasireotide looking at cell viability, cell cycle, apoptosis, GH secretion and tumour induced angiogenesis, pasireotide showed more potent anti-tumour activity than octreotide [12]. This evidence concerns the gene GH1 and neoplasm.